Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -11.48% is 85% above its 5-year average of -75.52%, near the high end of its 5-year range (-4322.37%–-3.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 72.48% above its 12-month average of -41.72%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -11.48%.
RETURN ON INVESTED CAPITAL (ROIC)
-11.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-41.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-68.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-75.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-168.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+72.48%
CURRENT VS 3Y AVG
+83.31%
CURRENT VS 5Y AVG
+84.80%
CURRENT VS 10Y AVG
+93.17%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+67.79%
vs the sector median at left
vTv Therapeutics Inc.
Market Cap
$78.44M
Return on Invested Capital (ROIC)
-11.48%
TTM Avg
-41.72%
3Y Avg
-68.79%
5Y Avg
-75.52%
Market Cap
$78.07M
Return on Invested Capital (ROIC)
-836.58%
TTM Avg
-213.85%
3Y Avg
-158.30%
5Y Avg
-121.35%
Market Cap
$78.55M
Return on Invested Capital (ROIC)
-88.72%
TTM Avg
-42.77%
3Y Avg
-39.33%
5Y Avg
-39.33%
Market Cap
$77.72M
Return on Invested Capital (ROIC)
-59.79%
TTM Avg
-61.79%
3Y Avg
-56.24%
5Y Avg
-67.61%
Market Cap
$79.40M
Return on Invested Capital (ROIC)
-88.28%
TTM Avg
-61.59%
3Y Avg
-48.92%
5Y Avg
-67.61%
Market Cap
$80.56M
Return on Invested Capital (ROIC)
-90.27%
TTM Avg
-103.33%
3Y Avg
-85.38%
5Y Avg
-72.83%
Market Cap
$76.56M
Return on Invested Capital (ROIC)
-33.27%
TTM Avg
-39.30%
3Y Avg
-47.63%
5Y Avg
-42.37%
Market Cap
$76.54M
Return on Invested Capital (ROIC)
-1.02%
TTM Avg
-7.84%
3Y Avg
-8.62%
5Y Avg
-7.82%
Market Cap
$76.24M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| vTv Therapeutics Inc. (VTVT) | $78.44M | -11.48% | -41.72% | -68.79% | -75.52% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | -836.58% | -213.85% | -158.30% | -121.35% |
| Citius Oncology, Inc. (CTOR)vs › | $78.55M | -88.72% | -42.77% | -39.33% | -39.33% |
| Sera Prognostics, Inc. (SERA)vs › | $77.72M | -59.79% | -61.79% | -56.24% | -67.61% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.40M | -88.28% | -61.59% | -48.92% | -67.61% |
| Humacyte, Inc. (HUMA)vs › | $80.56M | -90.27% | -103.33% | -85.38% | -72.83% |
| Outset Medical, Inc. (OM)vs › | $76.56M | -33.27% | -39.30% | -47.63% | -42.37% |
| SkinHealth Systems Inc. (SKIN)vs › | $76.54M | -1.02% | -7.84% | -8.62% | -7.82% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $76.24M | N/A | N/A | N/A | N/A |
| Nutriband Inc. (NTRB)vs › | $81.38M | -126.99% | -110.63% | -85.52% | -67.36% |
ROIC
-11.5%
ROE
-6.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -11.48% |
| 2026-03-31 | -3.31% |
| 2025-12-31 | -39.41% |
| 2025-09-30 | -33.25% |
| 2025-06-30 | -121.13% |
| 2025-03-31 | -90.42% |
| 2024-12-31 | -73.12% |
| 2024-09-30 | -65.31% |
| 2024-06-30 | -57.91% |
| 2024-03-31 | -52.37% |
| 2023-12-31 | -4322.37% |
| 2023-09-30 | -529.83% |
| 2023-06-30 | -208.97% |
| 2023-03-31 | -115.72% |
| 2022-12-31 | -87.52% |
| 2022-09-30 | -95.46% |
| 2022-06-30 | -85.48% |
| 2022-03-31 | -318.81% |
| 2021-12-31 | -125.71% |
| 2021-09-30 | -32.84% |
| 2021-06-30 | -59.95% |
| 2021-03-31 | -81.83% |
| 2020-12-31 | -139.71% |
| 2020-09-30 | -1793.57% |
| 2020-06-30 | -603.22% |
| 2019-12-31 | -1015.65% |
| 2019-09-30 | -677.38% |
| 2019-06-30 | -1517.52% |
| 2019-03-31 | -441.28% |
| 2017-12-31 | -963.72% |
| 2017-09-30 | -367.59% |
| 2017-06-30 | -212.46% |
| 2017-03-31 | -148.40% |
| 2016-12-31 | -127.77% |
| 2016-09-30 | -119.63% |
| 2016-06-30 | -85.52% |
| 2016-03-31 | -59.19% |
| 2015-12-31 | -45.51% |
| 2015-09-30 | -35.83% |
| 2015-06-30 | -626.53% |
| 2015-03-31 | -760.41% |
| 2014-12-31 | -462.94% |
